Targeted alpha-therapy with 211At-anti-mCD138 mAb in a syngeneic murine Multiple Myeloma model : can repeated doses or fractionation protocol overpass single dose efficiency? - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Papers Year : 2020

Targeted alpha-therapy with 211At-anti-mCD138 mAb in a syngeneic murine Multiple Myeloma model : can repeated doses or fractionation protocol overpass single dose efficiency?

Sébastien Gouard
  • Function : Author
  • PersonId : 1093736
Joëlle Gaschet
  • Function : Author
  • PersonId : 910960
Jean-François Gestin
François Guérard
Michel Chérel

Domains

Cancer
Fichier principal
Vignette du fichier
Gouard2020Eq13.pdf (200.14 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

inserm-03500243 , version 1 (22-12-2021)

Identifiers

Cite

Sébastien Gouard, Séverine Marionneau-Lambot, Joëlle Gaschet, Sébastien Chouin, F. Haddad, et al.. Targeted alpha-therapy with 211At-anti-mCD138 mAb in a syngeneic murine Multiple Myeloma model : can repeated doses or fractionation protocol overpass single dose efficiency?. 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2020, Virtuel, France. pp.S410-S411, ⟨10.1158/1078-0432.CCR-18-⟩. ⟨inserm-03500243⟩
30 View
32 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More